Abstract: The invention relates to the compounds 1,25-dihydroxy-16-ene-24-oxo-cholecalciferol and 1,24,25-trihydroxy-16-ene-cholecalciferol which stimulate differentiation of HL-60 cells, rendering them useful as an agent for the treatment of neoplastic diseases such as leukemia, and also decrease proliferation of human keratinocytes, rendering them useful as an agent for the treatment of hyperproliferative disorders of the skin such as psoriasis.
Type:
Grant
Filed:
October 1, 1993
Date of Patent:
March 28, 1995
Assignees:
Hoffmann-La Roche Inc., Satyanarayama G. Reddy
Inventors:
John A. McLane, Satyanarayama G. Reddy, Milan R. Uskokovic